|
Save up to 50% if you register now! |
| |
| |
| Moopuna: Home - About Moopuna - Search - Help | Login - Register Now |
| |
| |
| |
| |
| |
| |
|
Term Papers Categories Acceptance EssaysAlcohol & Drugs American History Anatomy & Physiology Animal Science Anthropology Architecture Arts Astronomy Aviation Biographies Biology Book Reports Business Chemistry Computers & Internet Creative Writing Current Events Economics Education Engineering English Environmental Issues Ethics European History Film & Cinema Foreign Languages Geography Government Health & Beauty Health Care History Human Sexuality Legal Issues Marketing Mathematics Medicine Movies Music Mythology Philosophy Physics Poetry Political Issues Political Science Psychology Religion Science Shakespeare Social Issues Sociology Speech & Communications Sports & Games Supernatural Issues Technology Theater World History Zoology | |
|
|
Johnson And Johnson, Inc.
The stock market, as evidenced by the events of the past several years, is a delicate thing. Uncertainties regarding the market abide with justification. Not many market participants foresaw the extent to which the world markets would be affected by the Asian financial crisis. The news of widespread financial failures in Southeast Asia and Japan hit the American, European, and Latin American markets with force, with net losses of 10%-50% and up of the total stock market value. Yet, within months many of the battered markets, especially the American markets, have rebounded to record highs. In the wake of President Clinton’s sex scandal and his recent impeachment, today’s stock market investor is posed with the serious threat of market volatility. Johnson and Johnson, Inc. (NYSE: JNJ) is a company that is very suitable for the needs of today’s cautious investor. It is one of the world’s largest and most diversified health care product makers, with total projected 1998 revenue of over $23 billion. The company operates in three sectors: consumer products (with brands like Tylenol and Motrin analgesics, Reach toothbrushes, Band-Aid bandages), professional products (contact lenses, surgical instruments, joint replacements), and pharmaceuticals (including cancer treatment, antihistamines, and oral contraceptives). Johnson and Johnson (J&J) is trading within the Drug Industry at a relatively low P/E of 31 and its EPS growth rate is at a modest 11.3%, but is expected to increase for the next year and into the future. Also, J&J is expecting approval from the FDA on new lines of drugs dealing with heart disease, cancer, and the like and to develop new medical treatments for pain management, allergies, orthopedics, and much more. Furthermore, J&J is posed to profit greatly witthe aging baby-boomer population approaching and passing the retirement age. Hence, with its strong future prospects and historically modest pricing, Johnson and... Please login to view comments from other users.
If you are having problems registering, please don't hesitate to contact us. | |||||||||||||||||||||||||
|
|
| Home | Register | Search | Help | Contact | Retrieve Password | Cancel Subscription | Privacy Policy | Disclaimer | Back to Top |
|
|
|
| © Copyright 1999-2007 Moopuna.com. All Rights Reserved. |